Drug Name and FDA Application Number | Dosage Form/Route | Strength | Marketing Status | Company |
ESCITALOPRAM OXALATE
(ANDA # 076765)
| TABLET; ORAL |
EQ 5MG BASE EQ 10MG BASE EQ 20MG BASE
|
Prescription
| IVAX PHARMS |
ESCITALOPRAM OXALATE
(ANDA # 077412)
| TABLET; ORAL |
5MG 10MG 20MG
|
Tentative Approval
| TEVA PHARMS |
ESCITALOPRAM OXALATE
(ANDA # 077512)
| TABLET; ORAL |
5MG 10MG 20MG
|
Tentative Approval
| ACTAVIS ELIZABETH |
ESCITALOPRAM OXALATE
(ANDA # 077550)
| TABLET; ORAL |
5MG 10MG 20MG
|
Tentative Approval
| MYLAN PHARMA |
ESCITALOPRAM OXALATE
(ANDA # 077660)
| CAPSULE; ORAL |
EQ 5MG BASE EQ 10MG BASE EQ 20MG BASE
|
Prescription
| ALPHAPHARM |
ESCITALOPRAM OXALATE
(ANDA # 077798)
| TABLET; ORAL |
5MG 10MG 20MG
|
Tentative Approval
| DR REDDYS LABS INC |
ESCITALOPRAM OXALATE
(ANDA # 078032)
| TABLET; ORAL |
5MG 10MG 20MG
|
Tentative Approval
| KALI LABS |
ESCITALOPRAM OXALATE
(ANDA # 078467)
| TABLET; ORAL |
5MG 10MG 20MG
|
Tentative Approval
| SANDOZ |
ESCITALOPRAM OXALATE
(ANDA # 078604)
| TABLET; ORAL |
5MG 10MG 20MG
|
Tentative Approval
| INVAGEN PHARMS |